Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
HKD 8.42
(0.0%)
HKD 8.42
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 540.39 Million HKD | -16.33% |
| 2022 | 645.87 Million HKD | 6.26% |
| 2021 | 607.83 Million HKD | 12.05% |
| 2020 | 542.45 Million HKD | -2.46% |
| 2019 | 556.11 Million HKD | -4.24% |
| 2018 | 580.72 Million HKD | 18.52% |
| 2017 | 489.96 Million HKD | 16.57% |
| 2016 | 420.31 Million HKD | 18.65% |
| 2015 | 354.24 Million HKD | 23.38% |
| 2014 | 287.12 Million HKD | 30.51% |
| 2013 | 220 Million HKD | 41.09% |
| 2012 | 155.93 Million HKD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 109.89 Million HKD | -19.89% |
| 2024 Q2 | 109.89 Million HKD | 0.0% |
| 2023 Q1 | 133.02 Million HKD | -38.31% |
| 2023 FY | 540.39 Million HKD | -16.33% |
| 2023 Q3 | 137.17 Million HKD | 3.12% |
| 2023 Q2 | 133.02 Million HKD | 0.0% |
| 2023 Q4 | 137.17 Million HKD | 0.0% |
| 2022 Q3 | 215.61 Million HKD | 0.46% |
| 2022 Q4 | 215.61 Million HKD | 0.0% |
| 2022 Q1 | 107.31 Million HKD | -68.49% |
| 2022 Q2 | 214.63 Million HKD | 100.0% |
| 2022 FY | 645.87 Million HKD | 6.26% |
| 2021 FY | 607.83 Million HKD | 12.05% |
| 2021 Q2 | 267.21 Million HKD | 100.0% |
| 2021 Q3 | 170.31 Million HKD | -36.27% |
| 2021 Q4 | 340.62 Million HKD | 100.0% |
| 2021 Q1 | 133.6 Million HKD | -57.7% |
| 2020 Q1 | 113.29 Million HKD | -42.65% |
| 2020 Q2 | 226.58 Million HKD | 100.0% |
| 2020 Q3 | 157.93 Million HKD | -30.29% |
| 2020 FY | 542.45 Million HKD | -2.46% |
| 2020 Q4 | 315.87 Million HKD | 100.0% |
| 2019 Q4 | 197.54 Million HKD | 100.0% |
| 2019 Q2 | 358.57 Million HKD | 100.0% |
| 2019 Q1 | 179.28 Million HKD | 31.24% |
| 2019 Q3 | 98.77 Million HKD | -72.45% |
| 2019 FY | 556.11 Million HKD | -4.24% |
| 2018 Q4 | 136.6 Million HKD | 0.0% |
| 2018 Q3 | 136.6 Million HKD | -8.14% |
| 2018 Q2 | 148.72 Million HKD | -6.34% |
| 2018 FY | 580.72 Million HKD | 18.52% |
| 2018 Q1 | 158.78 Million HKD | 47.21% |
| 2017 Q3 | 124.75 Million HKD | -0.03% |
| 2017 FY | 489.96 Million HKD | 16.57% |
| 2017 Q2 | 124.79 Million HKD | -5.85% |
| 2017 Q4 | 107.86 Million HKD | -13.54% |
| 2017 Q1 | 132.55 Million HKD | 53.27% |
| 2016 Q4 | 86.48 Million HKD | -17.85% |
| 2016 FY | 420.31 Million HKD | 18.65% |
| 2016 Q3 | 105.28 Million HKD | -12.37% |
| 2016 Q2 | 120.13 Million HKD | 10.81% |
| 2016 Q1 | 108.41 Million HKD | 11.74% |
| 2015 Q2 | 90.12 Million HKD | 8.58% |
| 2015 Q4 | 97.02 Million HKD | 15.37% |
| 2015 Q3 | 84.09 Million HKD | -6.69% |
| 2015 Q1 | 83 Million HKD | 4.02% |
| 2015 FY | 354.24 Million HKD | 23.38% |
| 2014 Q3 | 66.99 Million HKD | -9.39% |
| 2014 Q2 | 73.93 Million HKD | 11.34% |
| 2014 Q1 | 66.4 Million HKD | -15.87% |
| 2014 FY | 287.12 Million HKD | 30.51% |
| 2014 Q4 | 79.79 Million HKD | 19.11% |
| 2013 Q1 | 37.07 Million HKD | -43.83% |
| 2013 FY | 220 Million HKD | 41.09% |
| 2013 Q2 | 56.38 Million HKD | 52.06% |
| 2013 Q3 | 47.61 Million HKD | -15.54% |
| 2013 Q4 | 78.92 Million HKD | 65.76% |
| 2012 FY | 155.93 Million HKD | 0.0% |
| 2012 Q4 | 66.01 Million HKD | 86.29% |
| 2012 Q1 | 23.94 Million HKD | 0.0% |
| 2012 Q2 | 30.54 Million HKD | 27.55% |
| 2012 Q3 | 35.43 Million HKD | 16.02% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| China Healthwise Holdings Limited | -134.55 Million HKD | 501.606% |
| Tycoon Group Holdings Limited | 297.31 Million HKD | -81.755% |